Clinical Trial Update: Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies [Phase 3]

View source ↗

Summary

Phase 3 superiority study evaluating a preservative-free fixed-dose combination of tafluprost and timolol versus each monotherapy in ocular hypertension and ope…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• tafluprost-timolol preservative-free fixed-dose combination (tafluprost timolol)

Snippet

Sponsor: Santen Oy | Conditions: Ocular Hypertension, Open-angle Glaucoma | Phase 3 | Status: COMPLETED